Global cancer statistics

  title={Global cancer statistics},
  author={D. Max Parkin and Paola Pisani and Jacques Ferlay},
  journal={CA: A Cancer Journal for Clinicians},
Statistics are given for global patterns of cancer incidence and mortality for males and females in 23 regions of the world. 
Colorectal cancer—global burden, trends, and geographical variations
The aim of this study is to describe the trends and variations in the global burden of colorectal cancer (CRC).
Prostate cancer mortality rates in Peru and its geographical regions
To evaluate the mortality rates for prostate cancer according to geographical areas in Peru between 2005 and 2014, data is presented on the number of men diagnosed with prostate cancer in different areas of the country and their mortality rates.
Global trends in the burden of liver cancer
The aim of this study is to describe the influence of geography, socio‐economic development, and demographic shift on the trends in global incidence, mortality, and prevalence of liver cancer (LC).
Ovarian cancer in Western Australia (1982–98): incidence, mortality and survival
To investigate the trends in incidence and mortality and estimate survival for women diagnosed with ovarian cancer in Western Australia, a large number of women are diagnosed with the disease each year.
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England
Study Type – Prevalence (retrospective cohort) and Cause of Death – Unknown, unknown, no known mechanisms.
Laryngeal cancer: Global socioeconomic trends in disease burden and smoking habits
To characterize health burden and determine the associated level of equality of laryngeal carcinoma (LC) burden at a global level, data are collected on patients diagnosed with the disease over a 10-year period in order to establish a baseline level of health burden.
Quality Indicators for the Care of Breast Cancer in Vulnerable Elders
This study highlights the need to understand more fully the role that breastfeeding plays in the development of breast cancer and the individual’s risk of disease progression and recurrence.
Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015
This cohort study describes the incidence rates of 4 breast cancer molecular subtypes stratified by race/ethnicity among women in the US.
Patterns of care and treatment outcomes for elderly women with cervical cancer
The authors examined the patterns of care, treatment, and outcomes of elderly women with cervical cancer and found that older women are more likely to develop cervical cancer than their contemporaries.
Advance in predictive and prognostic marker assessments in lung cancer.
This poster focuses on lung cancer, which is the leading cause of cancer death worldwide and represents 19% of all cancer-related deaths and needs more research into.


Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996
To measure trends in recorded incidence and mortality rates of prostate cancer in Western Australia from 1985 to 1996 and to relate these to prostate specific antigen (PSA) testing for prostate
Prostate carcinoma incidence and patient mortality
Screening for and the aggressive treatment of prostate carcinoma are controversial, but they are nevertheless being practiced in the U.S. Current clinical studies of the effectiveness of screening
Cancer Incidence in Five Continents
  • F. Bray, J. Ferlay, D. Forman
  • Medicine
    Union Internationale Contre Le Cancer / International Union against Cancer
  • 1970
The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden
It is estimated that 20% of all cancer deaths (1 million) could be prevented by eliminating tobacco smoking, and mortality from cancers of the liver and uterine cervix, both major problems in developing countries, could be substantially reduced by immunization against hepatitis B virus infection and early detection through Pap smears, respectively.
Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk
It seems unlikely that the large ethnic differences in prostate cancer risk can be explained completely by ethnic differences in diet or other lifestyle characteristics. Instead, the differences may
Non-Hodgkin's lymphoma time trends: United States and international data.
Differences in non-Hodgkin's lymphoma rates persist between races and sexes, and increases have been more marked for extranodal disease, particularly those arising in the brain, and for high-grade tumors.
Prostate cancer.
Either potency-saving subcapsular prostatectomy or radiation therapy is effective in treating localized disease and new prospects for hormonal therapy of metastatic prostate cancer include antiandrogens and gonadotropin-releasing analogs.
International trends in incidence of cervical cancer: II. Squamous‐cell carcinoma
The predominant pattern shown by cancer registries in developed countries is of a reduction in the incidence of squamous cervical cancer, and the major exception is observed in the United Kingdom, though the increasing incidence in young women has changed to a decrease in recent years.
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990.
The increased use of sigmoidoscopy and fecal occult blood tests (triggering colonoscopy) appears to have played an important role in reducing colorectal cancer mortality and age-period-cohort analyses of mortality rates indicated a statistically significant moderation of colore CT cancer risk with both advancing birth cohorts and recent calendar periods.
Possible Underestimation of the Incidence Rate of Prostate Cancer in Japan
The adjusted incidence rate of prostate cancer in Japanese in Japan by this method is estimated to be between 24.9 and 33.3 per 100,000 population, based on incidence rates from the population‐based cancer registries of Miyagi, Japan, and Los Angeles and Hawaii, USA.